相似文献
1
Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.
Int J Mol Sci. 2012;13(5):5348-5363. doi: 10.3390/ijms13055348. Epub 2012 May 2.
2
Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors.
Int J Mol Sci. 2013 May 10;14(5):9947-62. doi: 10.3390/ijms14059947.
3
Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2'-(aminoaryl)benzothiazoles as Aurora-A inhibitors.
Chem Biol Drug Des. 2012 Jun;79(6):960-71. doi: 10.1111/j.1747-0285.2012.01366.x. Epub 2012 Apr 17.
4
Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors.
Bioorg Med Chem Lett. 2016 Jun 15;26(12):2855-2860. doi: 10.1016/j.bmcl.2016.04.057. Epub 2016 Apr 21.
5
Inhibition of serotonin synthesis: A novel therapeutic paradigm.
Pharmacol Ther. 2020 Jan;205:107423. doi: 10.1016/j.pharmthera.2019.107423. Epub 2019 Oct 17.
6
Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Bioorg Med Chem Lett. 2016 Feb 15;26(4):1124-9. doi: 10.1016/j.bmcl.2016.01.064. Epub 2016 Jan 22.
7
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5229-32. doi: 10.1016/j.bmcl.2009.07.005. Epub 2009 Jul 8.
8
Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
Future Med Chem. 2020 Aug;12(16):1461-1474. doi: 10.4155/fmc-2020-0127. Epub 2020 Aug 5.
9
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
J Med Chem. 2008 Jul 10;51(13):3684-7. doi: 10.1021/jm800338j. Epub 2008 Jun 17.
10
3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
Eur J Med Chem. 2009 Jul;44(7):2868-76. doi: 10.1016/j.ejmech.2008.12.008. Epub 2008 Dec 16.
引用本文的文献
1
Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole- and Investigations.
Front Pharmacol. 2020 Nov 26;11:593416. doi: 10.3389/fphar.2020.593416. eCollection 2020.
2
Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.
Sci Rep. 2016 Dec 5;6(1):3. doi: 10.1038/s41598-016-0007-2.
3
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
Drug Des Devel Ther. 2014 Sep 2;8:1195-210. doi: 10.2147/DDDT.S62921. eCollection 2014.
4
Design, synthesis, antifungal activities and 3D-QSAR of new N,N'-diacylhydrazines containing 2,4-dichlorophenoxy moiety.
Int J Mol Sci. 2013 Nov 1;14(11):21741-56. doi: 10.3390/ijms141121741.
5
Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.
Int J Mol Sci. 2013 Jul 9;14(7):14225-39. doi: 10.3390/ijms140714225.
6
Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors.
Int J Mol Sci. 2013 May 10;14(5):9947-62. doi: 10.3390/ijms14059947.
7
Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.
Int J Mol Sci. 2012 Nov 23;13(12):15668-78. doi: 10.3390/ijms131215668.
本文引用的文献
1
3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.
Molecules. 2011 Aug 8;16(8):6684-700. doi: 10.3390/molecules16086684.
2
Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2'-(aminoaryl)benzothiazoles as Aurora-A inhibitors.
Chem Biol Drug Des. 2012 Jun;79(6):960-71. doi: 10.1111/j.1747-0285.2012.01366.x. Epub 2012 Apr 17.
3
Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.
Int J Mol Sci. 2011;12(12):8713-39. doi: 10.3390/ijms12128713. Epub 2011 Dec 1.
4
The two faces of serotonin in bone biology.
J Cell Biol. 2010 Oct 4;191(1):7-13. doi: 10.1083/jcb.201006123.
5
Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening.
Molecules. 2010 Aug 9;15(8):5408-22. doi: 10.3390/molecules15085408.
6
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.
Nat Med. 2010 Mar;16(3):308-12. doi: 10.1038/nm.2098. Epub 2010 Feb 7.
7
Tryptophan hydroxylase as novel target for the treatment of depressive disorders.
Pharmacology. 2010;85(2):95-109. doi: 10.1159/000279322. Epub 2010 Feb 3.
8
3D-QSAR studies of arylcarboxamides with inhibitory activity on InhA using pharmacophore-based alignment.
Chem Biol Drug Des. 2010 Feb;75(2):195-203. doi: 10.1111/j.1747-0285.2009.00926.x. Epub 2009 Dec 17.
9
Bone: serotonin, leptin and the central control of bone remodeling.
Nat Rev Rheumatol. 2009 Dec;5(12):657-8. doi: 10.1038/nrrheum.2009.231.
10
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.
Cell. 2009 Sep 4;138(5):976-89. doi: 10.1016/j.cell.2009.06.051.
Zotero 插件
